Cargando…
Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice
Current schistosomiasis control strategies are mainly based on chemotherapy, but the development of a vaccine against this parasitic disease would contribute to a long-lasting decrease in disease spectrum and transmission. When it comes to vaccine candidates, several genes encoding Schistosoma manso...
Autores principales: | Morais, Suellen B., Figueiredo, Barbara C., Assis, Natan R. G., Homan, Jane, Mambelli, Fábio S., Bicalho, Rodrigo M., Souza, Cláudia, Martins, Vicente P., Pinheiro, Carina S., Oliveira, Sergio C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077287/ https://www.ncbi.nlm.nih.gov/pubmed/30105029 http://dx.doi.org/10.3389/fimmu.2018.01762 |
Ejemplares similares
-
Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation
por: Morais, Suellen B., et al.
Publicado: (2018) -
S. mansoni SmKI-1 Kunitz-domain: Leucine point mutation at P1 site generates enhanced neutrophil elastase inhibitory activity
por: Mambelli, Fábio, et al.
Publicado: (2021) -
Schistosome Syntenin Partially Protects Vaccinated Mice against Schistosoma mansoni Infection
por: Figueiredo, Barbara C., et al.
Publicado: (2014) -
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
por: Gonçalves de Assis, Natan Raimundo, et al.
Publicado: (2015) -
The role of the adaptor molecule STING during Schistosoma mansoni infection
por: Souza, Cláudia, et al.
Publicado: (2020)